Osteoarthritic synovial fluid and synovium supernatants up-regulate tumor necrosis factor receptors on human articular chondrocytes

Osteoarthritis and Cartilage

Volumn 6, Issue 3, 1998, Pages 167-176

  Webb, Ginette R ^b   Westacott, Carole I ^a   Elson, Christopher J ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b NONE

Author keywords

Human articular chondrocytes; IL 1; IL 6; Osteoarthritis; TNF receptors

Indexed keywords

PROTEIN P55; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT INTERLEUKIN 6; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CONCENTRATION RESPONSE; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; MALE; NORMAL HUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SYNOVIAL FLUID LEVEL;

EID: 17444448249     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1053/joca.1998.0109     Document Type: Article

References (30)

1. 1. Radin EL, Paul IL, Rose RM. Osteoarthritis as a common final pathway. In: Nuki, éd. The Aetiopathogenesis of Osteoarthrosis. Pitman Medical 1979:84-9.
2. 2. Cooke TD, Dwosh IL. Clinical features of osteoarthritis in the elderly. Clinics in Rheum Dis 1986;12:155-72.
3. 3. Dean DD, Martell-Pelletier JP, Howell DS, Woessner JF Jr. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 1989;84:678-85.
4. 4. Westacott CI, Taylor G, Atkins RM, Elson CJ. Interleukin-1α and β production by cells isolated from the membrane around aseptically loose total joint replacements. Ann Rheum Dis 1992;51:638-42.
5. 5. Elson CJ, Mortuza FY, Perry MP, Warnock MJ, Webb GR, Westacott CI. Cytokines and focal loss of cartilage in osteoarthritis, (letter) Br J Rheumatol 1998;37:106-7.
6. 6. Webb GR, Westacott CI, Elson CJ. Chondrocyte tumor necrosis factor receptors and focal loss of cartilage in osteoarthritis. Osteoarthritis Cart 1997;5:427-37.
7. 7. Westacott CI, Ismaiel S, Atkins RM, Langkamer VG, Elson CJ. Human articular cartilage degradation and chondrocyte expression of TNFα receptors. Trans Orth Res Soc 1993;18:739.
8. 8. Ismaiel S, Atkins RM, Pearse MF, Dieppe PA, Elson CJ. Susceptibility of normal and arthritic human articular cartilage to degradative stimuli. Br J Rheum 1992:31;369-73.
9. 9. Westacott CI, Atkins RM, Dieppe PA, Elson CJ. Tumor necrosis factor α receptor expression on chondrocytes isolated from human articular cartilage. J Rheum 1994:21;1710-5.
10. 10. Martel-Pelletier J, McCollum R, DiBattista JA et al. The interleukin-1 receptor in normal and osteoarthritic human articular chondrocytes: identification as the type I receptor and analysis of binding kinetics and biological function. Arthritis Rheum 1992:35;530-40.
11. 11. Sharif M, George E, Shepstone L et al. Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee. Arthritis Rheum 1995:38;760-7.
12. 12. Dieppe P, Cushnaghan J, Young P, Kirwan J. Prediction of progression of joint space narrowing in osteoarthritis of the knee by bone scintigraphy. Ann Rheum Dis 1993:52;557-63.
13. 13. Watanabe N, Kuriyama H, Sone H et al. Continuous internalisation of tumour necrosis factor receptors in a human myosarcoma cell line. J Cell Biol 1988:263;10262-6.
14. 14. Gatanaga T, Hwang C, Gatanaga M, Cappuccini F, Yamamoto R, Granger G. The regulation of TNF receptor mRNA synthesis, membrane expression and release by PMA and LPS stimulated human monocyte THP-1 cells in vitro. Cell Immunol 1991:138;-10.
15. 15. Perry MJ, Mortuza FY, Ponsford FM, Elson CJ, Atkins RM. Analysis of cell types and mediator production for tissues around loosening joint implants. Brit J Rheum 1995:34;1127-34.
16. 16. Bailey M, Williams NA, Wilson AD, Stokes CR. PROBIT: Weighted regression analysis for the estimation of biological activity. J Immunol Methods 1992:153;261-2.
17. 17. Shalaby MR, Sundan A, Loetscher H, Brockhaus M, Lesslauer W, Espevik T. Binding and regulation of cellular functions by monoclonal antibodies against tumor necrosis factor receptors. J Exp Med 1990:72;1517-20.
18. 18. Scheurich P, Köbrich G, Pfizenmaier K. Antagonistic control of tumor necrosis factor receptors by protein kinase a and c. J Exp Med 1989:170;947-58.
19. 19. Brockhaus M, Schoenfield HJ, Schlaeger EJ, Hunziker W, Lesslauer W, Loetscher H. Identification of two types of tumour necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 1990:87;3127-31.
20. 20. Winzen R, Wallach D, Kemper O, Resch K, Holtmann H. Selective up-regulation of the 75kDa tumor necrosis factor (TNF) receptor and its mRNA by TNF and IL-1. J Immunol 1993:150;4346-53.
21. 21. Van Bladel S, Libert C, Fiers W. Interleukin-6 enhances the expression of tumour necrosis factor receptors on hepatoma cells and hepatocytes. Cytokine 1991:3;149-54.
22. 22. Guerne P-A, Zuraw BL, Vaughan JH, Carson DA, Lotz M. Synovium as a source of interleukin 6 in vitro. J Clin Invest 1989:83;585-92.
23. 23. Farahat MN, Yanni G, Poston R, Panayi GS. Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 1993:52;870-6.
24. 24. Lotz M, Moats T, Villiger PM. Leukaemia inhibitory factor is expressed in cartilage and synovium and can contribute to the pathogenesis of arthritis. J Clin Invest 1992:90;888-96.
25. 25. Symons JA, Eastgate JA, Duff GW. A soluble binding protein specific for interleukin-1 beta is produced by activated mononuclear cells. Cytokine 2:1991;190-5.
26. 26. Fujikawa Y, Shingu M, Takehiko T, Masumi S. Interleukin-1 receptor antagonist production in cultured synovial cells from patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 1995:54;318-20.
27. 27. Erikstein BK, Smeland EB, Blomhoff HK et al. Independant regulation of 55kDa and 75kDa tumour necrosis factor receptors during the activation of human peripheral blood B lymphocytes. Eur J Immunol 1991:21;1033-7.
28. 28. Kalthoff H, Roeder C, Brockhaus M, Thiele H-G, Schmiegel W. Tumour necrosis factor (TNF) up-regulates the expression of p75 but not p55 TNF receptors, and both receptors mediate, independently of each other, up-regulation of transforming growth factor α and epidermal growth factor receptor mRNA. J Biol Chem 1993:268;2762-6.
29. 29. Kammermann JR, Kincaid SA, Rumph PF, Baird DK, Visco DM. Tumor necrosis factor-α (TNFα) in canine osteoarthritis: Immunolocalisation of TNFα stromelysin and TNF receptors in canine osteoarthritic cartilage. Osteoarthritis Cart 1996:4;23-34.
30. 30. Venn G, Nietfeld JJK, Duits AJ et al. Elevated synovial fluid levels of interleukin-6 and tumor necrosis factor associated with early experimental canine osteoarthritis. Arthritis Rheum 1993:36; 819-26.